DEBORAH WILKINS: Open Payments
NPI 1790873305 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 21 payments from 10 companies in 2025. Trend: 2023 $2,216 · 2024 $0 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| ABBVIE INC. | 4 | $68 |
| Lundbeck LLC | 2 | $60 |
| Alkermes, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Neos Therapeutics, LP | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Bausch Health US, LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: HETLIOZ, COBENFY, REXULTI, VRAYLAR, ARISTADA, Auvelity, Adzenys XR-ODT, SPRAVATO.
Industry payments across NC — which companies pay providers there.
